A new partnership will create a theranostics health care platform in the region with radiopharmaceutical production and therapy, molecular imaging, and clinical trials all at the same location. One ...

SHREVEPORT, La. - Starget Pharma Inc, a U.S. clinical-stage radiopharmaceutical company, announced the closing of its $18M Series A financing round and a strategic collaboration with the Center for Mo ...

A new molecular imaging agent can accurately identify a crucial biomarker found among many different types of cancer. Precise visualization of the trophoblast cell surface antigen 2 (Trop2) biomarker ...

Radiopharmaceutical therapy and molecular imaging—together known as Theranostics—are gaining significant traction worldwide. Even though Theranostics dates back to the early 1940s, a rapid expansion ...

A new light-based imaging approach has produced an unprecedented chemical map of the Alzheimer’s brain. Rice University researchers have produced what they describe as the first full, label-free ...

Researchers used advanced imaging to uncover early molecular changes in bone that may enable earlier diagnosis of ...

Transitioning molecular imaging from a preclinical technique to a standard clinical tool could help detect the very earliest stages of disease, reports Tami Freeman Tools of the trade Left: this ...

Novel approaches in molecular imaging and targeted therapeutics are transforming the management of renal cell carcinoma (RCC) and urothelial carcinoma (UC). This review focuses on three key areas of ...

Endometrial cancer represents the most prevalent gynecologic malignancy in high-income regions, where its management conventionally hinges on ...

Rice University scientists have developed the first complete, label-free molecular atlas of the Alzheimer's brain in an ...